Evidence map›Paper›PMID 35943523›Full record

ArticlePsychopharmacology2022

Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice.

Giulia Margiani, Maria Paola Castelli, Nicholas Pintori, Roberto Frau, Maria Grazia Ennas, Antonio C Pagano Zottola, Valeria Orrù, Valentina Serra, Edoardo Fiorillo, Paola Fadda and 2 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Psychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Deletion ofFrontiers in pharmacology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Giulia Margiani *Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Maria Paola Castelli *Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Nicholas PintoriDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Roberto FrauDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Maria Grazia EnnasDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Antonio C Pagano ZottolaINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Valeria OrrùInstitute for Genetic and Biomedical Research, National Research Council (CNR), Lanusei, Italy.
Valentina SerraInstitute for Genetic and Biomedical Research, National Research Council (CNR), Lanusei, Italy.
Edoardo FiorilloInstitute for Genetic and Biomedical Research, National Research Council (CNR), Lanusei, Italy.
Paola FaddaDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Giovanni MarsicanoINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Maria Antonietta De LucaDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy. deluca@unica.it.ORCID http://orcid.org/0000-0002-2647-4859
University of Cagliari · ITInstitute of Genetic and Biomedical Research · ITUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleThe use of synthetic cannabinoid receptor agonists (SCRAs) is growing among adolescents, posing major medical and psychiatric risks. JWH-018 represents the reference compound of SCRA-containing products.

objectivesThis study was performed to evaluate the enduring consequences of adolescent voluntary consumption of JWH-018.

methodsThe reinforcing properties of JWH-018 were characterized in male CD1 adolescent mice by intravenous self-administration (IVSA). Afterwards, behavioral, neurochemical, and molecular evaluations were performed at adulthood.

resultsAdolescent mice acquired operant behavior (lever pressing, Fixed Ratio 1-3; 7.5 µg/kg/inf); this behavior was specifically directed at obtaining JWH-018 since it increased under Progressive Ratio schedule of reinforcement, and was absent in vehicle mice. JWH-018 IVSA was reduced by pretreatment of the CB1-antagonist/inverse agonist AM251. Adolescent exposure to JWH-018 by IVSA increased, at adulthood, both nestlet shredding and marble burying phenotypes, suggesting long-lasting repetitive/compulsive-like behavioral effects. JWH-018 did not affect risk proclivity in the wire-beam bridge task. In adult brains, there was an increase of ionized calcium binding adaptor molecule 1 (IBA-1) positive cells in the caudate-putamen (CPu) and nucleus accumbens (NAc), along with a decrease of glial fibrillary acidic protein (GFAP) immunoreactivity in the CPu. These glial alterations in adult brains were coupled with an increase of the chemokine RANTES and a decrease of the cytokines IL2 and IL13 in the cortex, and an increase of the chemokine MPC1 in the striatum.

conclusionsThis study suggests for the first time that male mice self-administer the prototypical SCRA JWH-018 during adolescence. The adolescent voluntary consumption of JWH-018 leads to long-lasting behavioral and neurochemical aberrations along with glia-mediated inflammatory responses in adult brains.

Indexed as

Cannabinoid Receptor AgonistsChemokine CCL5AnimalsCalciumCalcium CarbonateGlial Fibrillary Acidic ProteinIndolesInterleukin-13Interleukin-2MaleMiceNaphthalenesReceptor, Cannabinoid, CB11-pentyl-3-(1-naphthoyl)indoleCalciumCalcium CarbonateCannabinoid Receptor AgonistsChemokine CCL5Glial Fibrillary Acidic ProteinIndolesInterleukin-13Interleukin-2NaphthalenesReceptor, Cannabinoid, CB1ChemokinesCytokinesGFAPIBA-1NeuroinflammationSynthetic cannabinoid receptor agonist

Identifiers

PMID35943523
PMCPMC9481487
OpenAlexW4290738696

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.